Vinca alkaloid compounds are a class of natural compounds extracted from the plant Catharanthus roseus. They belong to a class of nitrogen-containing alkaline compounds with a large number of natural secondary metabolites of plants. These alkaloids have multiple pharmacological activities, especially showing great potential in the treatment of cancer, cardiovascular and other diseases, and therefore have received extensive attention and research.
At present, a variety of vinca alkaloid compounds have been officially used in clinical practice or are in the clinical research stage, including but not limited to:
Vinblastine: an important anti-tumor terpenoid indole alkaloid, mainly used in the treatment of Hodgkin's disease and choriocarcinoma, and also has certain efficacy on lymphosarcoma, melanoma, ovarian cancer, leukemia, etc.
Vincristine: another important anti-tumor drug, with a similar pharmacological mechanism of action to vinblastine.
Vindesine and Vinorelbine: also commonly used vinca alkaloid anti-tumor drugs in clinical practice.
The global Vinca Alkaloid Compounds market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 169 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
As the number of cancer patients increases worldwide, the demand for anti-tumor drugs is also rising. Vinca alkaloid compounds, such as vincristine, vinblastine and vinorelbine, are important anti-tumor APIs and are widely used in various cancer drugs, and the market demand continues to grow. In recent years, the rise of precision medicine has made drug research and development pay more attention to targeted and personalized treatment. Vinca alkaloid compounds have great application potential in the field of precision medicine and are expected to further promote the growth of market demand.
With the increasing attention paid to the development of natural product drugs, the market for vinca alkaloid compounds has shown a growth trend. However, the content of these alkaloids in natural vinca plants is low, which is difficult to meet the growing market demand. Therefore, in the future, it is necessary to improve production efficiency through chemical synthesis, biosynthesis and other technical means to meet clinical applications and market needs.
At present, China is the largest market for vinca alkaloid compounds, accounting for about 53% of the market share, followed by Europe and North America, which together account for 15% of the market share. The main manufacturers are Pierre Fabre, Minakem, Baiyun Hanfang Modern Pharmaceutical, etc. The top three manufacturers account for about 40% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vinca Alkaloid Compounds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vinca Alkaloid Compounds.
The Vinca Alkaloid Compounds market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Vinca Alkaloid Compounds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vinca Alkaloid Compounds manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pierre Fabre
Minakem
Guangzhou Hanfang Pharmaceutical
Hainan Vinca biological medicine technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Vinkem
Hansoh
Min Sheng
Zhendong Group
Qilu Pharmaceutical
Segment by Type
Vincristine
Vinorelbine
Vindesine
Segment by Application
Lymphoma
Breast Cancer
Lung Cancer
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vinca Alkaloid Compounds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vinca Alkaloid Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Vinca Alkaloid Compounds 麻豆原创 Overview
1.1 Product Definition
1.2 Vinca Alkaloid Compounds by Type
1.2.1 Global Vinca Alkaloid Compounds 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Vincristine
1.2.3 Vinorelbine
1.2.4 Vindesine
1.3 Vinca Alkaloid Compounds by Application
1.3.1 Global Vinca Alkaloid Compounds 麻豆原创 Value by Application (2024-2030)
1.3.2 Lymphoma
1.3.3 Breast Cancer
1.3.4 Lung Cancer
1.3.5 Others
1.4 Global Vinca Alkaloid Compounds 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vinca Alkaloid Compounds Revenue 2019-2030
1.4.2 Global Vinca Alkaloid Compounds Sales 2019-2030
1.4.3 Global Vinca Alkaloid Compounds 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vinca Alkaloid Compounds 麻豆原创 Competition by Manufacturers
2.1 Global Vinca Alkaloid Compounds Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Vinca Alkaloid Compounds Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Vinca Alkaloid Compounds Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Vinca Alkaloid Compounds, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vinca Alkaloid Compounds, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vinca Alkaloid Compounds, Product Type & Application
2.7 Global Key Manufacturers of Vinca Alkaloid Compounds, Date of Enter into This Industry
2.8 Global Vinca Alkaloid Compounds 麻豆原创 Competitive Situation and Trends
2.8.1 Global Vinca Alkaloid Compounds 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Vinca Alkaloid Compounds Players 麻豆原创 Share by Revenue
2.8.3 Global Vinca Alkaloid Compounds 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vinca Alkaloid Compounds 麻豆原创 Scenario by Region
3.1 Global Vinca Alkaloid Compounds 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vinca Alkaloid Compounds Sales by Region: 2019-2030
3.2.1 Global Vinca Alkaloid Compounds Sales by Region: 2019-2024
3.2.2 Global Vinca Alkaloid Compounds Sales by Region: 2025-2030
3.3 Global Vinca Alkaloid Compounds Revenue by Region: 2019-2030
3.3.1 Global Vinca Alkaloid Compounds Revenue by Region: 2019-2024
3.3.2 Global Vinca Alkaloid Compounds Revenue by Region: 2025-2030
3.4 North America Vinca Alkaloid Compounds 麻豆原创 Facts & Figures by Country
3.4.1 North America Vinca Alkaloid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vinca Alkaloid Compounds Sales by Country (2019-2030)
3.4.3 North America Vinca Alkaloid Compounds Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vinca Alkaloid Compounds 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vinca Alkaloid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vinca Alkaloid Compounds Sales by Country (2019-2030)
3.5.3 Europe Vinca Alkaloid Compounds Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vinca Alkaloid Compounds 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Vinca Alkaloid Compounds 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vinca Alkaloid Compounds Sales by Region (2019-2030)
3.6.3 Asia Pacific Vinca Alkaloid Compounds Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vinca Alkaloid Compounds 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vinca Alkaloid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vinca Alkaloid Compounds Sales by Country (2019-2030)
3.7.3 Latin America Vinca Alkaloid Compounds Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vinca Alkaloid Compounds 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vinca Alkaloid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vinca Alkaloid Compounds Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vinca Alkaloid Compounds Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vinca Alkaloid Compounds Sales by Type (2019-2030)
4.1.1 Global Vinca Alkaloid Compounds Sales by Type (2019-2024)
4.1.2 Global Vinca Alkaloid Compounds Sales by Type (2025-2030)
4.1.3 Global Vinca Alkaloid Compounds Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Vinca Alkaloid Compounds Revenue by Type (2019-2030)
4.2.1 Global Vinca Alkaloid Compounds Revenue by Type (2019-2024)
4.2.2 Global Vinca Alkaloid Compounds Revenue by Type (2025-2030)
4.2.3 Global Vinca Alkaloid Compounds Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Vinca Alkaloid Compounds Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vinca Alkaloid Compounds Sales by Application (2019-2030)
5.1.1 Global Vinca Alkaloid Compounds Sales by Application (2019-2024)
5.1.2 Global Vinca Alkaloid Compounds Sales by Application (2025-2030)
5.1.3 Global Vinca Alkaloid Compounds Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Vinca Alkaloid Compounds Revenue by Application (2019-2030)
5.2.1 Global Vinca Alkaloid Compounds Revenue by Application (2019-2024)
5.2.2 Global Vinca Alkaloid Compounds Revenue by Application (2025-2030)
5.2.3 Global Vinca Alkaloid Compounds Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Vinca Alkaloid Compounds Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pierre Fabre
6.1.1 Pierre Fabre Company Information
6.1.2 Pierre Fabre Description and Business Overview
6.1.3 Pierre Fabre Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pierre Fabre Vinca Alkaloid Compounds Product Portfolio
6.1.5 Pierre Fabre Recent Developments/Updates
6.2 Minakem
6.2.1 Minakem Company Information
6.2.2 Minakem Description and Business Overview
6.2.3 Minakem Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Minakem Vinca Alkaloid Compounds Product Portfolio
6.2.5 Minakem Recent Developments/Updates
6.3 Guangzhou Hanfang Pharmaceutical
6.3.1 Guangzhou Hanfang Pharmaceutical Company Information
6.3.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview
6.3.3 Guangzhou Hanfang Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guangzhou Hanfang Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
6.3.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
6.4 Hainan Vinca biological medicine technology
6.4.1 Hainan Vinca biological medicine technology Company Information
6.4.2 Hainan Vinca biological medicine technology Description and Business Overview
6.4.3 Hainan Vinca biological medicine technology Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hainan Vinca biological medicine technology Vinca Alkaloid Compounds Product Portfolio
6.4.5 Hainan Vinca biological medicine technology Recent Developments/Updates
6.5 Guangzhou Person Pharmaceutical
6.5.1 Guangzhou Person Pharmaceutical Company Information
6.5.2 Guangzhou Person Pharmaceutical Description and Business Overview
6.5.3 Guangzhou Person Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangzhou Person Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
6.5.5 Guangzhou Person Pharmaceutical Recent Developments/Updates
6.6 Hainan Yueyang Biotechnology
6.6.1 Hainan Yueyang Biotechnology Company Information
6.6.2 Hainan Yueyang Biotechnology Description and Business Overview
6.6.3 Hainan Yueyang Biotechnology Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hainan Yueyang Biotechnology Vinca Alkaloid Compounds Product Portfolio
6.6.5 Hainan Yueyang Biotechnology Recent Developments/Updates
6.7 Hubei Honch Pharmaceutical
6.7.1 Hubei Honch Pharmaceutical Company Information
6.7.2 Hubei Honch Pharmaceutical Description and Business Overview
6.7.3 Hubei Honch Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hubei Honch Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
6.7.5 Hubei Honch Pharmaceutical Recent Developments/Updates
6.8 Fine Chemicals Corporation
6.8.1 Fine Chemicals Corporation Company Information
6.8.2 Fine Chemicals Corporation Description and Business Overview
6.8.3 Fine Chemicals Corporation Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fine Chemicals Corporation Vinca Alkaloid Compounds Product Portfolio
6.8.5 Fine Chemicals Corporation Recent Developments/Updates
6.9 Vinkem
6.9.1 Vinkem Company Information
6.9.2 Vinkem Description and Business Overview
6.9.3 Vinkem Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vinkem Vinca Alkaloid Compounds Product Portfolio
6.9.5 Vinkem Recent Developments/Updates
6.10 Hansoh
6.10.1 Hansoh Company Information
6.10.2 Hansoh Description and Business Overview
6.10.3 Hansoh Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hansoh Vinca Alkaloid Compounds Product Portfolio
6.10.5 Hansoh Recent Developments/Updates
6.11 Min Sheng
6.11.1 Min Sheng Company Information
6.11.2 Min Sheng Description and Business Overview
6.11.3 Min Sheng Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Min Sheng Vinca Alkaloid Compounds Product Portfolio
6.11.5 Min Sheng Recent Developments/Updates
6.12 Zhendong Group
6.12.1 Zhendong Group Company Information
6.12.2 Zhendong Group Description and Business Overview
6.12.3 Zhendong Group Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhendong Group Vinca Alkaloid Compounds Product Portfolio
6.12.5 Zhendong Group Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Company Information
6.13.2 Qilu Pharmaceutical Description and Business Overview
6.13.3 Qilu Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qilu Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vinca Alkaloid Compounds Industry Chain Analysis
7.2 Vinca Alkaloid Compounds Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vinca Alkaloid Compounds Production Mode & Process
7.4 Vinca Alkaloid Compounds Sales and 麻豆原创ing
7.4.1 Vinca Alkaloid Compounds Sales Channels
7.4.2 Vinca Alkaloid Compounds Distributors
7.5 Vinca Alkaloid Compounds Customers
8 Vinca Alkaloid Compounds 麻豆原创 Dynamics
8.1 Vinca Alkaloid Compounds Industry Trends
8.2 Vinca Alkaloid Compounds 麻豆原创 Drivers
8.3 Vinca Alkaloid Compounds 麻豆原创 Challenges
8.4 Vinca Alkaloid Compounds 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pierre Fabre
Minakem
Guangzhou Hanfang Pharmaceutical
Hainan Vinca biological medicine technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Vinkem
Hansoh
Min Sheng
Zhendong Group
Qilu Pharmaceutical
听
听
*If Applicable.